Wang Xiaolin 4
4 · Revolution Medicines, Inc. · Filed Mar 21, 2022
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Sale
Common Stock
2022-03-17$18.61/sh−240$4,467→ 31,698 total
Footnotes (3)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]This transaction was executed in multiple trades in prices ranging from $18.1558 to $18.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 28,400 RSUs.